Mirza Ammar Arshad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mirza Ammar Arshad has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Abu Huraira Bin Gulzar
Department of Medicine Services Institute of Medical Sciences Lahore Pakistan
2 shared publications - Asad Ali Ahmed Cheema
Department of Medicine, International School of Medicine, International University of Kyrgyzstan, Bishkek, Kyrgyzstan
2 shared publications Nimra Shafi
2 shared publications- Abraham Titus
Department of Hematology-Oncology, University of South Alabama, Mobile, AL
1 shared publication Abu Huraira Bin Gulzar
Services Institute of Medical Sciences, Lahore, Pakistan
1 shared publication- Ahmed Shajeeh1 shared publication
Latest Publications
- 4 November 2026
- Published by Elsevier in Heart & Lung
- Vol. 81
Efficacy and safety of add-on sotatercept therapy for pulmonary arterial hypertension. A systematic review and meta-analysis
- 4 November 2026
- Published by Elsevier in Heart & Lung
- Vol. 81
Efficacy and safety of add-on sotatercept therapy for pulmonary arterial hypertension. A systematic review and meta-analysis
- Open Access
- 23 June 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (6) , e70392
Trends and Disparities in Acute Myocardial Infarction‐Related Mortality With Co‐Listed Nicotine Dependence in the United States, 1999–2020
Background: Nicotine use is a major modifiable risk factor for acute myocardial infarction (AMI), yet national mortality patterns involving co‐listed nicotine dependence remain under‐characterized. Methods: Using CDC WONDER Multiple Cause of Death data from 1999 to 2020, we evaluated AMI‐related mortality among US adults aged ≥ 25 years with co‐listed death‐certificate‐coded nicotine dependence, operationally defined using ICD‐10 F17.0–F17.9. AMI was identified using ICD‐10 I21.0–I22.9. Age‐adjusted mortality rates (AAMRs) per 100 000 population were calculated using the 2000 US standard population. Temporal trends were assessed using Joinpoint regression and stratified by sex, age, race/ethnicity, region, urbanization, state, and place of death. Results: From 1999 to 2020, 357 167 AMI‐related deaths with co‐listed nicotine dependence occurred among adults aged ≥ 25 years. The AAMR increased from 1.64 to 9.46 per 100 000 population (average annual percent change, 10.27%; p < 0.001). Men had higher AAMRs than women (11.30 vs. 4.27), with significant increases in both groups. Mortality increased with age, highest among adults aged ≥ 85 years (33.55) and lowest among those aged 35–44 years (0.83). Non‐Hispanic American Indian/Alaska Native adults had the highest AAMR (10.30). Rates were higher in the Midwest and South, nonmetropolitan areas exceeded metropolitan areas, and the highest state‐level AAMRs occurred in North Dakota and Wyoming. Most deaths occurred in inpatient facilities or at home. Conclusion: AMI‐related mortality with co‐listed nicotine dependence increased substantially from 1999 to 2020, with persistent demographic and geographic disparities. These findings may inform targeted tobacco‐control, nicotine‐cessation, and cardiovascular prevention strategies for high‐risk populations over time.
- 23 June 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (6) , e70392
Open AccessTrends and Disparities in Acute Myocardial Infarction‐Related Mortality With Co‐Listed Nicotine Dependence in the United States, 1999–2020
Background: Nicotine use is a major modifiable risk factor for acute myocardial infarction (AMI), yet national mortality patterns involving co‐listed nicotine dependence remain under‐characterized. Methods: Using CDC WONDER Multiple Cause of Death data from 1999 to 2020, we evaluated AMI‐related mortality among US adults aged ≥ 25 years with co‐listed death‐certificate‐coded nicotine dependence, operationally defined using ICD‐10 F17.0–F17.9. AMI was identified using ICD‐10 I21.0–I22.9. Age‐adjusted mortality rates (AAMRs) per 100 000 population were calculated using the 2000 US standard population. Temporal trends were assessed using Joinpoint regression and stratified by sex, age, race/ethnicity, region, urbanization, state, and place of death. Results: From 1999 to 2020, 357 167 AMI‐related deaths with co‐listed nicotine dependence occurred among adults aged ≥ 25 years. The AAMR increased from 1.64 to 9.46 per 100 000 population (average annual percent change, 10.27%; p < 0.001). Men had higher AAMRs than women (11.30 vs. 4.27), with significant increases in both groups. Mortality increased with age, highest among adults aged ≥ 85 years (33.55) and lowest among those aged 35–44 years (0.83). Non‐Hispanic American Indian/Alaska Native adults had the highest AAMR (10.30). Rates were higher in the Midwest and South, nonmetropolitan areas exceeded metropolitan areas, and the highest state‐level AAMRs occurred in North Dakota and Wyoming. Most deaths occurred in inpatient facilities or at home. Conclusion: AMI‐related mortality with co‐listed nicotine dependence increased substantially from 1999 to 2020, with persistent demographic and geographic disparities. These findings may inform targeted tobacco‐control, nicotine‐cessation, and cardiovascular prevention strategies for high‐risk populations over time.
- 13 March 2025
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 25 (8) , e553-e562
Analyzing Two Decades of Leukemia Mortality in the U.S. (1999-2020)
- 13 March 2025
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 25 (8) , e553-e562
Analyzing Two Decades of Leukemia Mortality in the U.S. (1999-2020)